Neuronetics (STIM) Receivables (2017 - 2026)

Neuronetics (STIM) has 10 years of Receivables data on file, last reported at $16.6 million in Q1 2026.

• On a quarterly basis, Receivables fell 39.89% year-over-year to $16.6 million in Q1 2026; TTM through Mar 2026 was $16.6 million, a 39.89% decrease from a year earlier, with the FY2025 full-year figure at $17.5 million, down 30.74% from the prior year.
• Receivables for Q1 2026 stood at $16.6 million, down from $17.5 million in the prior quarter.
• Over the last five years, Receivables for STIM reached as high as $27.6 million in Q1 2025 and fell as low as $10.1 million in Q1 2022.
• Historically, Receivables has averaged $17.5 million across 5 years, with a median of $16.6 million in 2026.
• Across the five-year window, Receivables soared 66.22% in 2022 and sank 39.89% in 2026, its largest moves.
• Year by year, Receivables stood at $15.2 million in 2022, then grew by 3.56% to $15.8 million in 2023, then jumped by 60.21% to $25.3 million in 2024, then plunged by 30.74% to $17.5 million in 2025, then slipped by 5.27% to $16.6 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $16.6 million in Q1 2026, $17.5 million in Q4 2025, and $19.8 million in Q3 2025.